Suchergebnisse - "Kleinmann, Jean-François"

PubPharm (12)

1

Refining Incidence and Characteristics of Inflammatory Myopathies : A Quadruple-Source Capture-Recapture Survey Using the 2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria

enthalten in: Arthritis & rheumatology (Hoboken, N.J.) | 2023

von Debrut, L. | Giannini, M. | Klein, D. | +19

2

Tolerance and efficacy of targeted therapies prescribed for off-label indications in refractory systemic autoimmune diseases : data of the first 100 patients enrolled in the TATA registry (TArgeted Therapy in Autoimmune Diseases)

enthalten in: RMD open | 2022

von Gottenberg, J. | Chaudier, A. | Allenbach, Y. | +44

3

Difficulties and Psychological Impact of the SARS-CoV-2 Pandemic in Patients with Systemic Lupus Erythematosus : A Nationwide Patient Association Study

enthalten in: Healthcare (Basel, Switzerland) | 2022

von Scherlinger, M. | Zein, N. | Gottenberg, J. | +4

4

Incidence and predictors of COVID-19 and flares in patients with rare autoimmune diseases : a systematic survey and serological study at a national reference center in France

enthalten in: Arthritis research & therapy | 2021

von Felten, R. | Scherlinger, M. | Guffroy, A. | +14

5

Incidence and predictors of COVID-19 and flares in patients with rare autoimmune diseases: a systematic survey and serological study at a national reference center in France

enthalten in: Arthritis Research & Therapy | 2021

von Felten, R. | Scherlinger, M. | Guffroy, A. | +14

6

Infliximab is an effective glucocorticoid-sparing treatment for Takayasu arteritis : Results of a multicenter open-label prospective study

enthalten in: Autoimmunity reviews | 2020

von Mertz, P. | Kleinmann, J. | Lambert, M. | +19

7

Contribution of rare and predicted pathogenic gene variants to childhood-onset lupus : a large, genetic panel analysis of British and French cohorts

enthalten in: The Lancet. Rheumatology | 2020

von Belot, A. | Rice, G. | Omarjee, S. | +100

ErratumIn: Lancet Rheumatol. 2020 Nov;2(11):e664. - PMID 38279362

8

Lupus Regulator Peptide P140 Represses B Cell Differentiation by Reducing HLA Class II Molecule Overexpression

enthalten in: Arthritis & rheumatology (Hoboken, N.J.) | 2018

von Wilhelm, M. | Wang, F. | Schall, N. | +7

9

International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosus

enthalten in: Autoimmunity reviews | 2017

von Kleinmann, J. | Tubach, F. | Le Guern, V. | +60

10

Long-term efficacy and safety of antitumour necrosis factor alpha treatment in rhupus : an open-label study of 15 patients

enthalten in: RMD open | 2017

von Danion, F. | Sparsa, L. | Arnaud, L. | +16